Stay updated on Dolutegravir Kinetics in Primary HIV: Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir Kinetics in Primary HIV: Clinical Trial page.

Latest updates to the Dolutegravir Kinetics in Primary HIV: Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe record now presents details of the completed DOLUPRIM study, including its eligibility criteria, treatment and study design, outcomes, enrollment, and study dates. It also indicates that the study is no longer recruiting participants.SummaryDifference37%

- Check16 days agoChange DetectedThe footer now displays site revision v3.8.0 instead of v3.7.2, while the study record remains inaccessible behind a 403 error.SummaryDifference0.2%

- Check23 days agoChange DetectedA site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the study page’s 403 error message.SummaryDifference1%

- Check30 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2; the study record page still displays a 403 error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check51 days agoChange DetectedThe error-page markup and related navigation were removed, signaling the study record will render as a regular page instead of an access-denied response.SummaryDifference0.5%

Stay in the know with updates to Dolutegravir Kinetics in Primary HIV: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir Kinetics in Primary HIV: Clinical Trial page.